Epigenomic reprogramming via HRP2-MINA dictates response to proteasome inhibitors in multiple myeloma with t(4;14) translocation.
Wang J, Zhu X, Dang L, Jiang H, Xie Y, Li X, Guo J, Wang Y, Peng Z, Wang M, Wang J, Wang S, Li Q, Wang Y, Wang Q, Ye L, Zhang L, Liu Z.
Wang J, et al. Among authors: zhu x.
J Clin Invest. 2022 Feb 15;132(4):e149526. doi: 10.1172/JCI149526.
J Clin Invest. 2022.
PMID: 35166240
Free PMC article.